Found 99,413 cases where Vaccine targets Shingles (VARZOS) and Submission Date on/before '2018-05-31'
Result pages: prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 next
Days after onset: 11
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1012F / 1 - / -
Administered by: Unknown Purchased by: Unknown
Symptoms: Herpes zoster, Pain
SMQs:, Opportunistic infections (broad)
Write-up: Day after receiving shingles vaccine, pt developed shingles-type pain. 4 days after vaccine pt developed full zoster outbreak.
Days after vaccination: 40
Days after submission: 5
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK RA / SC
Symptoms: Back pain, Condition aggravated, Pain, Sleep disorder
SMQs:, Retroperitoneal fibrosis (broad)
Permanent Disability? Yes
ER Visit? Yes
Other Medications: Tylenol, Allopurinol, aspirin, Carbatrol, Furosemide, Synthroid, Zocor, Spironolactone.
Preexisting Conditions: Upper extremity mass, mass excision, gout, skin cancer, cellulitis, heart attack, cholelithiasis, Arthritis, coronary artery disease, shingles, cholesterol levels raised.
CDC Split Type: WAES0611USA00187
Write-up: Information has been received from a medical assistant and an 89 year old female consumer with arthritis, increased cholesterol levels, coronary artery disease and shingles. since 9/28/1992 and a history of a mass in the right hand with surgery, gout, skin cancer on her face in 1984, cellulitis, cholelithiasis in 1978 and a heart attack in 1988 and 1989, she had angiogram in 1990 and a 30% double vessel occlusion. On 9/6/06 was vaccinated SC in the right arm with a dose of Varicella zoster virus vaccine live. There was no concomitant vaccinations. Concomitant therapy included Carbatrol, Allopurinol, Synthroid, Simvastatin, Spironolactone, aspirin and Tylenol. The pt thought that one shot of the vaccine would cure her shingles. It was noted that the pt was not experiencing pain from the injection site. the medical assistant also stated that the pt had pain from a previous shingles experience, however, the pain is reportedly worse since receiving the vaccine. The pt was worse later in the day and has interrupted the pts ability to sleep at night. It was reported that the pt did not experienced a rash. The pt had reported that she was previously seen by a neurologist, had acupuncture but nothing works for her shingles. About 3 weeks ago, on approx 10/16/06, the pt was experiencing severe pain in her back area after receiving varicella zoster virus vaccine live. At the time of this report, the pt had not recovered. It was reported that the pts experienced were disabling. Additional information has been requested.
Sex: Unknown
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN
Symptoms: Medication error, Wrong drug administered
Other Medications: UNK
Preexisting Conditions: UNK
Write-up: Information has been received from a physician concerning a patient who was vaccinated with a dose of varicella-zoster virus vaccine live instead of varicella virus vaccine live. The patient was supposed to be vaccinated with varicella virus vaccine live to prevent chickenpox. The physician reported that there was no product confusion. There was no product quality complaint involved. Additional information from the physician indicated that the problem with the product confusion was that both of the vaccines have varicella vaccine in one form or another on the product and that caused product confusion for the medica assistant. Additional information has been requested.
Symptoms: Herpes zoster, Viral infection
Write-up: Information has been received from a healthcare worker concerning an adult male pt who on approx 9/17/06 was vaccinated with a dose of Varicella Zoster Vaccine Live. the pt returned to the physicians office about one week later, on approx 9/24/06 with shingles. A product quality complaint was not involved. Additional information has been requested.
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0623F / UNK RA / -
Symptoms: Erythema, Herpes zoster, Pain, Rash papular, Rash pruritic
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)
Preexisting Conditions: Chickenpox
Diagnostic Lab Data: Body temp, 10/03/2006, normal; VZV strain, 10/05/2006, specimen was inadequate
Write-up: Information has been received from a 70 year old male physician with no allergies and a history of chickenpox as a child and no recent exposure to chickenpox or herpes zoster and no other medical history who on 10-AUG-2006 was vaccinated in the right upper arm with a 0.5 ml dose of ZOSTAVAX (lot #652966/0623F). There was no concomitant medication. On 10-AUG-2006 and 11-AUG-2006, the patient had erythema at the injection site. On 03-OCT-2006, the patient developed shingles after vaccination. He had four lesions on the left lower anterior abdomen. Three of the lesions were clustered and the one lesion was outward. He described the symptoms as "shingles, unilateral, erythematous papules, and a surrounding pallor-like a halo." He mentioned that he was not experiencing any pain, but there was itchiness involved. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information was received from the patient who reported that on 05-OCT-2006 he collected and would be submitting lesion (papule) specimens. He had two slides and a cotton swab. He noted that he developed "four itchy papular lesions, three in a cluster and one by itself on the left side - T-11 dermatone." He did not have any pain currently, but would evaluate the pain initially at a three out of a scale of 10. He was very concerned that the vaccination was causing a reactivation of natural VZV disease to present now as herpes zoster or that it was actually causing the herpes zoster. Additional information was received from the patient who reported that the date of onset of the herpes zoster was 03-OCT-2006. The area of involvement included the right lower anterior abdomen at T-11. There were found lesions, three in a cluster and out outlier. His body temperature was noted to be normal. He rated his pain as 3 to 4 on a scale of 1 to 10, with 10 being the most. He had no other systemic symptoms and subsequently recovered. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the vaccine VZV strain. Results indicated that the specimen was inadequate, negative for B-globin, no strain ID. No further information is expected.
Symptoms: Injection site erythema, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Preexisting Conditions: shingles
Write-up: Information has been received from a physician concerning a female with a history of shingles who on 02-OCT-2006 was vaccinated with a 0.65 mL dose of ZOSTAVAX. On 02-OCT-2006 the patient experienced swelling and redness around the injection site and shoulder and neck. Unspecified medical attention was sought. Subsequently the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Symptoms: Herpes zoster
Write-up: Information has been received from a physician concerning a male who on 13-SEP-2006 was vaccinated with a 0.65 ml dose of ZOSTAVAX. Subsequently "two to three weeks after vaccination," on approximately 27-SEP-2006, the patient developed shingles. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Symptoms: Drug level decreased
SMQs:, Lack of efficacy/effect (narrow)
Other Medications: RITUXAN
Write-up: Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of ZOSTAVAX. Concomitant therapy included rituximab (RITUXAN). Subsequently, the patient may have possibly experienced decrease in rituximab (RITUXAN) levels after vaccination. The pharmacist could not provide any further information and was not reporting an adverse experience. The patient sought unspecified medical attention. No product quality complaint was involved. No further information is available.
Symptoms: Back pain, Discomfort, Herpes zoster, Pain, Viral infection
SMQs:, Retroperitoneal fibrosis (broad), Opportunistic infections (broad)
Write-up: Information has been received from a physician concerning a 72 year old female who on 10/06/2006 was vaccainted with a dose of Varicella Zoster vaccine. On 10/09/2006 the pt complained of pain mid back radiating to under the right breast. On 10/10/06 the physician reported that no rash was currently present. it was reported that two days after vaccination the pt developed shingles. the pts husband reported that his wife was vaccainted at her primary care physicians office on 10/05/06. On 10/10/06, the pt revisited her primary care physician and was diagnosed with an outbreak of shingles. the physician prescribed Famvir 500 mg and Tylenol with Codeine 3. At the time of the report, the pt was coping with the pain and discomfort of shingles and had not recovered. Additional information has been requested.
Days after onset: 164
Days after submission: 126
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 UN / SC
Symptoms: Balance disorder, Gingival abscess, Nausea, Pyrexia, Vertigo
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)
Other Medications: Aspirin, Calcium, Synthroid, Prinivil, Claritin, Vitamins
Current Illness: Abscess Oral; general symptoms; drug hypersensitivity; anxiety disorder
Preexisting Conditions: Sinus infection, breast calcification, gallbladder disorder, cholecystectomy,
Diagnostic Lab Data: Blood pressure 11/10/06 134/70, blood glucose 10/10/06 94
Write-up: Information has been received from a 67 year old female registered Nurse with chronic mucitis and an allergy to ampicillin and a history of sinus infection, calcium in breast and cholecystectomy (removed in past) who on 10/6/06 was vaccinated SC with a dose of Varicella Zoster vaccine. Concomitant therapy included Claritin, Lisinopril, Vitamins unspecified, calcium unspec vitamin D unspec, Synthroid, baby aspirin and Cortisone gel. On 10/10/06 at 16:00, the pt developed nausea, vertigo and loss of balance. She felt better lying down and closing her eyes. She felt like the room was spinning. No vomiting or diarrhea was noted. She had not taken her temp, but if she has a fever it is low grade. The pt currently has an abscess in her mouth currently which she has an appointment to be seen on 10/11/06. She reported that her blood pressure had been stable and she dose not have diabetes. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2006. Information has been received from a 67 year old female Registered Nurse with "chronic mucitis", anxiety disorder and an allergy to ampicillin and a history of sinus infections, calcium in breasts and cholecystectomy (removed in past) who on 06-OCT-2006 was vaccinated SC with a first dose of VARIVAX (Merck) (lot # 652965/0622F). Concomitant therapy included CLARITIN, lisinopril (manufacturer unknown), vitamins (unspecified), calcium (unspecified) (+) vitamin D (unspecified), SYNTHROID, baby aspirin and "cortizone gel". On 10-OCT-2006 at 16:00, the patient developed nausea, vertigo and loss of balance. She felt better lying down and closing her eyes. She felt like the room was spinning. No vomiting or diarrhea was noted. She had not taken her temperature, but if she had a fever "it is low grade". The patient currently has an abcess in her mouth currently which she has an appointment to be seen on 11-OCT-2006. She reported that her blood pressure had been stable and she does not have diabetes. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information from the physician indicated that the patient was vaccinated at a pharmacy. No significant problems were noted in the patient''s chart. The patient''s symptoms were reported resolved on 30-OCT-2006. The physician reported that it was unclear whether related to the vaccine. Laboratory tests included an office visit on 30-OCT-2006 for a "blood issue". No further information is expected.
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=8&VAX=VARZOS&VAXTYPES=Shingles&SUB_YEAR_HIGH=2018&SUB_MONTH_HIGH=05